---
$id: https://graph.org.ai/products/commodity/51282302
$type: Product
source: UNSPSC
code: "51282302"
title: "Clarithromycin"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clarithromycin

**UNSPSC Code**: 51282302
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic with the molecular formula C38H69NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H1250JIK0A, chemically known as erythromycin, 6-o-methyl- but generally known as clarithromycin, which bears US NIH Compound Identifier 54688. European Medicines Agency schedules Clarithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06641MIG. The term CLARITHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules clarithromycin in its Anatomical Therapeutic Chemical (ATC) Classification. CLARITHROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clarithromycin under HS 29415000 and SITC 54139. As of Q4 2014, CLARITHROMYCIN remains the US FDA Preferred Term for this commodity. Clarithromycin bears US NLM identifiers UMLS ID C0055856 and NCI Concept Code C1054. SMILES: O(C1C(C(OC2OC(C(O)C(OC)(C2)C)C)C(C(=O)OC(C(O)(C(O)C(C(=O)C(CC1(OC)C)C)C)C)CC)C)C)C1OC(CC(N(C)C)C1O)C.

